Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Hepatares Co-Founder to Helm Merck's New R&D Center in the UK January 21, 2018 5 Tasty Takeover Targets for 2018 January 14, 2018 Protalix BioTherapeutics Treatment for Ulcerative Colitis Shows Positive Data March 12, 2018
